Showing results (141-150 of 239) with videos related to

Sort By:
Pageof 24
Journal Des Maladies Vasculaires|April 16, 2016
Low incidence of cancer after venous thromboembolism: An update from the French OPTIMEV CohortA-C Arnoult, G Pernod, C Genty, et al.
Bulletin Du Cancer|September 8, 1999
[Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer: multicentric retrospective study II. DNA-ploidy and S-phase fraction]A Chassevent, M L Jourdan, M Ferrero-Poüs, et al.
Clinical Endocrinology|November 1, 1993
Two different pathogenetic mechanisms may play a role in acne and in hirsutismV Toscano, R Balducci, P Bianchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001
S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric studyA Chassevent, M L Jourdan, S Romain, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 8, 1999
[Evaluation of a series of 137 carcinomas of the endometrium of stage I TNM/UICC]M Bolla, J de Cornulier, E Berland, et al.
Revue D'Epidemiologie Et De Sante Publique|November 14, 2009
[Time trends in the geographic variation of thyroid cancer incidence by tumor size from 1983 to 2000 in France]C Leux, M Colonna, A V Guizard, et al.
European Journal of Immunology|November 28, 2000
Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicityH Nakajima, M Cella, A Bouchon, et al.
Tissue Antigens|February 12, 1998
HLA-A typing: comparison between serology, the amplification refractory mutation system with polymerase chain reaction and sequencingC Pera, L Delfino, A Morabito, et al.
European Journal of Cancer (Oxford, England : 1990)|February 10, 2007
A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983-2000)M Colonna, A V Guizard, C Schvartz, et al.
The Journal of Experimental Medicine|January 7, 1998
A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cellsM Colonna, F Navarro, T Bellón, et al.
Pageof 24